Our Team
Researchers, clinicians, and staff working across disciplines to translate discovery into better cancer care.
Principal Investigator
HYE RYUN, KIM M.D., Ph.D
Professor, Division of Medical Oncology, Yonsei Cancer Center
Email: [email protected]
Research publications (174)
- 2026 Neoadjuvant pembrolizumab with therapeutic DNA vaccine reshape intratumoral immunity in a phase 2 trial of HPV-positive HNSCC
- 2025 Single‐cell multi‐omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK‐positive lung cancer
- 2025 Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma
Medical Advisors
CHANG GON, KIM M.D., Ph.D
Clinical Associate Professor
Email: [email protected]
Research publications (5)
- 2025 Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma
- 2025 Circulating tumor cell-based molecular responses stratify EGFR-TKI efficacy in EGFR-mutant lung cancer patients
- 2025 4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy
Research Development
JAEHYUNG, KIM, Ph.D
Research Professor
Email: [email protected]
Research publications (1)
- 2025 4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy
GAMIN, KIM
Research Staff
Research publications (8)
- 2025 Single‐cell multi‐omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK‐positive lung cancer
- 2025 Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma
- 2025 Circulating tumor cell-based molecular responses stratify EGFR-TKI efficacy in EGFR-mutant lung cancer patients
WONRAK, SON Ph.D
Senior Researcher
Research publications (4)
- 2025 Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma
- 2025 Circulating tumor cell-based molecular responses stratify EGFR-TKI efficacy in EGFR-mutant lung cancer patients
- 2025 Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses
SEOK HYUNG, GO, Ph.D
Post-Doc
JUNG A, KIM
MS Course Student
JINHYOUNG, KIM MS
Researcher
IN HWAN, JANG, Ph.D
Post-Doc
Email: [email protected]
Chang seop Lee
Researcher
Email: [email protected]
Administrative Staff
👤
HYEJU, CHOI
Administrator
MIN JUNG, HWANG
Secretary
Email: [email protected]
KYUNG, LEE
Clinical Research Coordinator
YEONG JU, AHN
Research Assistant
Join Our Team
🩺
Clinical Researchers
Join our clinical research team working on innovative cancer treatments.
Learn More →🎓
Graduate Students
Graduate research opportunities in translational medicine and oncology.
Get Involved →